சக கூட்கலிப்பே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சக கூட்கலிப்பே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சக கூட்கலிப்பே Today - Breaking & Trending Today

Pendulum Therapeutics Raises $54 million


Pendulum Therapeutics Raises $54 million
Gut health biotech company Pendulum Therapeutics recently announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and Khosla Ventures.
The Series C round nearly doubled the entirety of Pendulum’s previous raises, bringing the total venture capital raised to $111 million.
As lead investor, Meritech General Partner Craig Sherman will take a seat on the Pendulum Board of Directors alongside Roelof Botha, a partner at Sequoia, and Adam D’Augelli, a partner at True Ventures.
“We think Pendulum is a next generation pharma company doing next generation gene sequencing,” ​said Sherman. ....

Roelof Botha , Colleen Cutcliffe , Craig Sherman , Pacific Biosciences , Adam Daugelli , Meritech General Partner Craig Sherman , Pendulum Board , Adamd Augelli , Pendulum Glucose , Glucose Control , Pendulum Therapeutics , Pendulum Glucose Control , Gut Health , சக கூட்கலிப்பே , கிரேக் ஷெர்மன் , பெஸிஃபிக் உயிர் அறிவியல் , ஊசல் பலகை , ஊசல் சிகிச்சை , குடல் ஆரோக்கியம் ,

Pandemic impacted our gut health and gut bacteria


Pandemic impacted our gut health and gut bacteria
Exercise, a healthy diet, being outside helps your gut
Over the last few years, probiotics and gut health have been all the rage in taking care of our microbiome, which is the bacteria living inside of us.
and last updated 2021-04-08 14:34:35-04
Over the last few years, probiotics and gut health have been all the rage in taking care of our microbiome, which is the bacteria living inside of us.
The pandemic has had a negative effect on our microbiome which relies on various diverse bacteria to function properly. Since we haven t traveled, touched people or things that diverse bacteria isn t finding its way into our bodies. ....

Colleen Cutcliffe , சக கூட்கலிப்பே ,

Pendulum Therapeutics Raises $54 Million to Meet Surging Customer Demand


Pendulum Therapeutics Raises $54 Million to Meet Surging Customer Demand
Strong Loyalty Among Subscribers: After Five Months, 74% of Key Customer Segment Remain Active Users
Company Created New Product Category, Filling Market Gap Between Supplements and Prescription Drugs
News provided by
Share this article
SAN FRANCISCO, April 7, 2021 /PRNewswire/  
Pendulum Therapeutics – a biotech company improving health through products targeting the microbiome – today announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and Khosla Ventures. This Series C round nearly doubled the entirety of Pendulum s previous raises and brings the total venture capital raised to $111 million. ....

San Francisco , United States , Roelof Botha , Colleen Cutcliffe , Craig Sherman , Nora Murray , Adam Daugelli , Sequoia Capital , Meritech Capital , True Ventures , Meritech General Partner , Pendulum Board , Pendulum Glucose Control , Glucose Control , Khosla Ventures , Mayo Clinic , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , சக கூட்கலிப்பே , கிரேக் ஷெர்மன் , நோரா முர்ரே , சீக்வோயா மூலதனம் , ஊசல் பலகை , கோசில முயற்சிகள் , மயோ சிகிச்சையகம் ,

NAD supports claims being made by 'medical probiotic' manufacturer


NAD supports claims being made by ‘medical probiotic’ manufacturer
©Getty Images - Image Jungle
Probiotics manufacturer Pendulum Therapeutics Inc. got some welcome news today when the National Advertising Division announced that it has found that the claims the company makes for dietary control of Type 2 diabetes are supported by scientific evidence.
The NAD ruling said that the scientific study that Pendulum Therapeutics submitted in response to the action support the claims it has been making.  The specific claims the ruling said were supported on the Pendulum Glucose Control product are:
“The only medical probiotic clinically shown to lower A1C & blood glucose spikes for the dietary management of T2D ( Consult your physician as part of your total diabetes management plan. Results may vary from person to person)”;​ and ....

United States , Colleen Cutcliffe , Diabetes Research , Pendulum Therapeutics , Pendulum Glucose Control , Nutraingredients United States , Glucose Control , Blood Sugar Management , Gut Digestive Health , Healthy Aging , Probiotics Amp Prebiotics , Product Claims , Health Claims , Health Claims Regulation , Diabetes Mellitus Type 2 , ஒன்றுபட்டது மாநிலங்களில் , சக கூட்கலிப்பே , நீரிழிவு நோய் ஆராய்ச்சி , ஊசல் சிகிச்சை , இரத்தம் சர்க்கரை மேலாண்மை , குடல் செரிமான ஆரோக்கியம் , ப்ராடக்ட் கூற்றுக்கள் , ஆரோக்கியம் கூற்றுக்கள் , ஆரோக்கியம் கூற்றுக்கள் ஒழுங்குமுறை ,